Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin C. McHenry is active.

Publication


Featured researches published by Martin C. McHenry.


The Annals of Thoracic Surgery | 1990

Sternal wound complications after isolated coronary artery bypass grafting: Early and late mortality, morbidity, and cost of care ☆

Floyd D. Loop; Bruce W. Lytle; Delos M. Cosgrove; Saade Mahfood; Martin C. McHenry; Marlene Goormastic; Robert W. Stewart; Leonard A.R. Golding; Paul C. Taylor

Of 6,504 consecutive patients who underwent isolated coronary bypass grafting in 1985 to 1987, 72 (1.1%) patients experienced sternal wound complications. Ten patients (14%) with wound complications died of multi-system failure. Only the patients with negative cultures fared well; of the bacterial culture categories, polymicrobial infection carried the worst prognosis. Effects of recurring infection were seen throughout the first year. Patients, grouped according to conduits received, experienced these wound complication rates: vein grafts only, 11/1,085 (1.0%); one internal thoracic artery, 38/4,073 (0.9%); and bilateral internal thoracic artery grafts, 23/1,346 (1.7%). There were no significant differences in wound complication rates between primary and reoperation patients or among conduit groups. By logistic regression analysis, the relative risk for patients with diabetes and bilateral internal thoracic artery grafting was 5.00 (95% confidence interval, 2.4 to 10.5). Operation time as a continuous variable increased the relative risk of wound complication 1.47 times per hour (1.3 to 1.7); obesity, 2.90 times (1.8 to 4.8); and blood units as continuous variable, 1.05 times per unit (1.01 to 1.10). Bilateral internal thoracic artery grafting in nondiabetic patients carried no greater risk of wound complication than that in patients with vein grafts only or with one internal thoracic artery graft.


Clinical Infectious Diseases | 2002

Vertebral Osteomyelitis: Long-Term Outcome for 253 Patients from 7 Cleveland-Area Hospitals

Martin C. McHenry; Kirk A. Easley; Geri A. Locker

We report a retrospective study of 253 patients with vertebral osteomyelitis (VO) who had long-term follow-up. Eleven percent of the patients died, residual disability occurred in more than one-third of the survivors, and relapse occurred in 14%. Median duration of follow-up was 6.5 years (range, 2 days to 38 years). Independent risk factors for adverse outcome (death or qualified recovery) were neurologic compromise, time to diagnosis, and hospital acquisition of infection (P< or =.004). Surgical treatment resulted in recovery or improvement in 86 (79%) of 109 patients. Magnetic resonance images (110 patients) were often obtained late in the course of infection and did not significantly affect outcome. Often, relapse developed in individuals with severe vertebral destruction and abscesses, appearing some time after surgical drainage or debridement. Recurrent bacteremia, paravertebral abscesses, and chronically draining sinuses were independently associated with relapse (P< or =.001). An optimal outcome of VO requires heightened awareness, early diagnosis, prompt identification of pathogens, reversal of complications, and prolonged antimicrobial therapy.


Medicine | 1979

Infective endocarditis caused by slow-growing, fastidious, gram-negative bacteria

Jerrold J. Ellner; Melvin S. Rosenthal; Phillip I. Lerner; Martin C. McHenry

In a review of endocarditis caused by fastidious, slow-growing gram-negative rods, similarities in the spectrum of disease overshadow differences among cases grouped by specific organisms. Cardiobacterium hominis, Actinobacillus actinomycetemcomitans and Haemophilus species usually seed previously damaged cardiac valves presumably during bacteremia from an upper respiratory site. The clinical presentation resembles that of Streptococcus viridans endocarditis and is usually subacute or chronic. Despite bacteriologic cure, severe CHF and/or systemic embolization frequently develops during or following the course of antibiotics, resulting in significant morbidity and a high mortality rate. This report of nine cases diagnosed at five hospitals in a 7-year period suggests that endocarditis due to these organisms is more common than previously appreciated and frequently goes unrecognized. This is probably due to a lack of attention to the requirements for culture of this group of bacteria with propensity for granular growth in broth. We have proposed specific cultural techniques appropriate to the search for these organisms in patients with apparent culture-negative endocarditis.


Medicine | 2000

Aspergillus valve endocarditis in patients without prior cardiac surgery.

Tawanda Gumbo; Alan J. Taege; Steven D. Mawhorter; Martin C. McHenry; Bruce Lytle; Delos M. Cosgrove; Steven M. Gordon

Aspergillus native valve endocarditis in patients who have not had cardiac surgery is uncommon. We report 3 cases and review 58 other adult patients reported in the English-language literature. Sixty-seven percent of the patients had underlying immunosuppression. The clinical features were fever (74%), embolic episodes (69%), a new or changing heart murmur (41%), and sudden visual loss (13%). Patients with mural endocarditis were more often immunosuppressed, especially due to solid organ transplants, but had lower frequency of heart murmurs and embolic episodes. Echocardiography revealed a vegetation in 78% of all the cases in which it was performed. Examination and culture of biopsy material often helped to establish a diagnosis of Aspergillus infection. Twenty-five patients had an antemortem diagnosis. These patients received a mean cumulative amphotericin B dose of 27 mg/kg. Twenty percent (3/15) of patients who received combined surgical and medical therapy survived, compared to none of those who received medical therapy alone (p = 0.08). Patients who survived were not immunosuppressed. We conclude that native valve aspergillus infective endocarditis is uniformly fatal without surgical intervention and antifungal therapy.


Pacing and Clinical Electrophysiology | 1990

Infections in Implantable Cardioverter Defibrillator Patients

Douglas Wunderly; James D. Maloney; Thomas B. Edel; Martin C. McHenry; Patrick M. McCarthy

Implantable cardioverter de;fibrillators fICDsj have been documented as an effective modality in reducing arrhythmic mortality. A serious complication associated with implantation of the device is infection. Few studies have addressed this issue. Two hundred seven patients with refractory ventricular arrhythmias underwent 207 ICD implantations, and 56 subcutaneous generator changes at our institution. Eight patients developed wound infections, four following ICD implantation (4 out of 207 or 1.9%), and four following a generator change (4 out of 56 or 7.1%). Wound cultures most commonly revealed Staphylococcus aurous and Staphylococcus epidermidis. Infections treated with antibiotics alone, or with only generator removal, frequently recurred (four out of five attempts). There were no recurrences following total patch/lead and generator system removal. In jive patients, the same generator unit was successfully emplaned following ethylene oxide sterilization without infection recurrence. We conclude that treatment of device‐associated infection generally requires total generator and patch/lead system removal, and that generator units can be successfully reimplanted yielding substantial cost savings.


Gastroenterology | 1986

Liver abscess in Crohn's disease: Report of four cases and review of the literature

Seid Hossein Mir-Madjlessi; Martin C. McHenry; Richard G. Farmer

Four patients with liver abscesses and Crohns disease are described, and reports of 14 cases in the English language literature are reviewed. The incidence of liver abscess in patients with Crohns disease (114-297 per 100,000) appears to be higher than that of liver abscess in the general population (8-16 per 100,000). Frequently the clinical manifestations of liver abscess are mistaken for a reactivation of Crohns disease, and diagnosis is delayed. In comparison to patients with liver abscess in the general population, patients with Crohns disease and liver abscess are considerably younger, are more likely to have multiple rather than solitary abscesses, and usually have a predisposing intraabdominal focus of infection, rather than a biliary one. Streptococci, especially Streptococcus milleri, are the most frequent cause of liver abscess in patients with Crohns disease. Liver scanning should be performed routinely in patients with Crohns disease in whom a febrile illness cannot be completely explained by bowel disease, or in whom fever does not respond to drainage of intraabdominal abscesses.


Transplantation | 1975

The fate of cadaver renal allografts contaminated before transplantation.

Guy C. Mccoy; Stefan Loening; William E. Braun; Magnus O. Magnusson; Lynn H. Banowsky; Martin C. McHenry

Through the routine use of cultures from saline slush transport solution and the initial and final organ perfusates, 14 of 81 cadaver allografts (17.3%) were found to have been contaminated before transplantation. Gram negative organisms, cultured from 5 of the 14 contaminated allografts, resulted in the recipients death on the first encounter with this problem and the loss of two other allografts. Early antibiotic therapy begun even without evidence of overt infection appeared to prevent any further deaths or graft loss in those whose allografts were contaminated and yielded an overall survival comparable to that of uncontaminated allografts. Without such an approach to the study of perfused cadaver allografts and the management of them when found to be contaminated, this type of infection may go undetected and contribute to allograft and patient loss.


The New England Journal of Medicine | 1977

Unusual Serum Lipoprotein Abnormality Induced by the Vehicle of Miconazole

Adolfo G. Bagnarello; Lena A. Lewis; Martin C. McHenry; Allan J. Weinstein; Herbert K. Naito; Arthur J. McCullough; Richard J. Lederman; Thomas L. Gavan

Miconazole, a phenethylimidazole,1 is effective in vitro against several pathogenic fungi,1 , 2 and has cured systemic mycoses in man.3 , 5 In contrast to amphotericin B, miconazole does not appear...


Journal of Bone and Joint Surgery, American Volume | 1974

Antibiotic concentrations in human bone. A preliminary report.

Michael C. Kolczun; Carl L. Nelson; Martin C. McHenry; Thomas L. Gavan; Patricia Pinovich

Fifty patients who underwent total hip arthroplasty were given oxacillin preoperatively and intraoperatively. Simultaneous specimens of bone and serum were obtained during the operation and assayed for oxacillin content. The different doses and modes of administration were compared with respect to antibiotic concentration in bone and in serum. Significant oxacillin bone levels were attainable when oxacillin was appropriately administered.


Transplantation | 1988

A multivariate analysis of risk factors for pneumonia following cardiac transplantation

Margaret J. Gorensek; Robert W. Stewart; Thomas F. Keys; Atul C. Mehta; Martin C. McHenry; Marlene Goormastic

Fifty cardiac transplant recipients were followed over a 34-month period for evidence of pneumonia that developed in twelve patients. Potential risk factors evaluated fell into three categories: demographic (age, sex, race, and underlying cardiac disease); pretransplant status (hospitalized, intubated, pulmonary infiltrate, requirement for antibiotics, or the need for a ventricular assist device); and posttransplant therapy (amount and type of blood products, prolonged endotracheal intubation or reintubation, use of ventricular assist devices, immunosuppressive protocols, lymphocyte subset ratios, and occurrence of rejection, leukopenia, or CMV infection). The Cox proportional hazards model identified posttransplant reintubation (P = 0.009) and the use of protocols employing larger steroid dosages (P = 0.02) as significant risk factors for pneumonia. In a separate analysis, the occurrence of pneumonia was shown to be a significant risk factor for mortality (P = 0.018).

Collaboration


Dive into the Martin C. McHenry's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge